No Data
No Data
Hualu Biotech: 2024 Semi-Annual Report
Hualu Biotech: Summary of the 2024 Semi-Annual Report
Hualv Biology (300970.SZ): The net loss in the first half of the year was 44.8245 million yuan.
On August 27th, Huasheng Bio (300970.SZ) released its semi-annual report for 2024. During the reporting period, the company's revenue was 0.463 billion yuan, a decrease of 12.45% year-on-year. The net loss attributable to shareholders of the listed company was 44.8245 million yuan, a change from profit to loss. The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 45.8423 million yuan, a change from profit to loss. The basic loss per share was 0.3840 yuan/share.
Huagreen Biological (300970.SZ) released its first half financial performance with a net loss of 44.8245 million yuan, a switch from profit to loss.
Huagre Bio (300970.SZ) released its 2024 interim report, with a revenue of 0.463 billion yuan for the company...
Huacheng Biology (stock code 300970.SZ): Has repurchased 1.99% of its shares.
On August 2nd, Gelunhui announced that up to July 31, 2024, the company repurchased 2,346,600 shares of the company through the Shenzhen Stock Exchange's stock trading system through centralized competitive trading, accounting for 1.99% of the company's current total share capital, with a highest fill price of 13.83 yuan/share, a lowest fill price of 12.22 yuan/share, and a total fill amount of 30,004,629.29 yuan (excluding transaction fees).
Hualv Biology (300970.SZ): Cumulative repurchase of 1.99% of shares.
On July 1st, Gelonhui reported that Huacheng Biology (300970.SZ) repurchased 2,346,600 shares of the company through the Shenzhen Stock Exchange stock trading system in a centralized bidding trading method until June 30, 2024, accounting for 1.99% of the company's current total share capital. The highest and lowest transaction prices were 13.83 yuan/share and 12.22 yuan/share respectively, with a total transaction amount of RMB 30,004,629.29 (excluding transaction fees).
No Data
No Data